[小而密低密度脂蛋白浓度与血清载脂蛋白B密切相关,非低密度脂蛋白胆固醇或低密度脂蛋白胆固醇的比较]

[Small dense LDL concentration is closely associated with serum apolipoprotein B, comparisons of non-LDL cholesterol or LDL cholesterol].

作者信息

Hayashi Toshiyuki, Hirano Tsutomu, Shiobara Tomomi, Suguro Toshiaki, Adachi Mitsuru

机构信息

First Department of Internal Medicine, Showa University School of Medicine, Tokyo.

出版信息

Rinsho Byori. 2006 Jun;54(6):569-75.

DOI:
Abstract

Small dense low-density lipoprotein (sd LDL) is more atherogenic than large buoyant (lb) LDL, which is relatively high in particle number (as estimated by apolipoprotein [apo] B) and poor in cholesterol (C) content. Because recent epidemiological studies have shown that serum apo B is a stronger predictor of the risk of coronary heart disease (CHD) than LDL-C, we assumed that this strong predictive power of apo B for CHD is attributable to a close association with sd LDL concentration. On the other hand, non-HDL-C has been proposed as an integrated CHD risk marker containing all atherogenic apo B-containing lipoproteins. We examined which apo B or non-HDL-C is superior marker in reflecting sd-LDL particles. Eighty-one subjects with dyslipidemia were studied. Sd LDL (density, 1.044 approximately .063g/ml) and large buoyant LDL (density, 1.019 approximately 1.044g/ml) were separated by the ultracentrifugation method and LDL size was measured by gradient gel electrophoresis. LDL-C, non-HDL-C, and apo B were highly associated with each other(r=0.78 approximately 0.87), and all were associated with C, apo B, and TG in sd-LDL. However, multivariate regression analysis revealed that only apo B was constantly and independently associated with sd-LDL concentrations. Mean LDL diameter was negatively associated with apo B but not with non-HDL-C. These results suggest that apo B is superior to non-HDL-C in reflecting a potent atherogenic lipoprotein, sd-LDL, which may explain a potent predictive power of apo B for CHD.

摘要

小而密的低密度脂蛋白(sd LDL)比大而轻的(lb)LDL更具致动脉粥样硬化性,后者的颗粒数量相对较高(以载脂蛋白[apo]B估算)而胆固醇(C)含量较低。由于最近的流行病学研究表明,血清apo B比LDL-C更能有力地预测冠心病(CHD)风险,我们推测apo B对CHD的这种强大预测能力归因于其与sd LDL浓度密切相关。另一方面,非HDL-C已被提议作为包含所有致动脉粥样硬化的含apo B脂蛋白的综合CHD风险标志物。我们研究了哪种apo B或非HDL-C在反映sd-LDL颗粒方面是更优的标志物。对81名血脂异常患者进行了研究。通过超速离心法分离sd LDL(密度,1.044约至0.063g/ml)和大而轻的LDL(密度,1.019约至1.044g/ml),并通过梯度凝胶电泳测量LDL大小。LDL-C、非HDL-C和apo B彼此高度相关(r = 0.78约至0.87),并且所有这些都与sd-LDL中的C、apo B和甘油三酯(TG)相关。然而,多变量回归分析显示,只有apo B始终且独立地与sd-LDL浓度相关。平均LDL直径与apo B呈负相关,但与非HDL-C无关。这些结果表明,在反映一种强效致动脉粥样硬化脂蛋白sd-LDL方面,apo B优于非HDL-C,这可能解释了apo B对CHD的强大预测能力。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索